M. Loebinger (London, United Kingdom), E. Van Braeckel (Ghent, Belgium)
Validation of the Nontuberculous Mycobacteria (NTM) Module in NTM Lung Disease
C. Deshpande (Bethesda, United States of America), A. Quittner (Miami, United States of America), E. Chou (Bridgewater, United States of America), R. Shah (Bethesda, United States of America), S. Bose (Bethesda, United States of America), K. Lasch (Boston, United States of America), Q. Zhang (Bridgewater, United States of America)
|  |
In vitro susceptibility to rifampin and ethambutol and treatment outcome in MAC lung disease
B. Kwon (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), H. Sung (Seoul, Republic of Korea), Y. Koh (Seoul, Republic of Korea), W. Kim (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea), Y. Oh (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), C. Lim (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), S. Hong (Seoul, Republic of Korea), S. Park (Dongtan, Republic of Korea), T. Shim (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea)
|   |
The clinical significance of Mycobacterium triplex isolates in Queensland, Australia
J. Gibson (Brisbane, Australia), T. Baird (Brisbane, Australia), S. Pandy (Brisbane, Australia), C. Tolson (Brisbane, Australia), C. Coulter (Brisbane, Australia), G. Eather (Brisbane, Australia), R. Thomson (Brisbane, Australia)
| |
Bronchiectasis in Oceania – survival and health care in Indigenous and non-Indigenous populations
G. Maguire (Melbourne, Australia), S. Blackall (Cairns, Australia), J. Hong (Auckland, New Zealand), P. King (Melbourne, Australia), C. Wong (Auckland, New Zealand), L. Einsiedel (Alice Springs, Australia), M. Rémond (Melbourne Springs, Australia), C. Woods (Armidale Springs, Australia)
| |
Population based survey on the NTM pulmonary disease treatment in Japan
K. Izumi (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Uchimura (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan)
| |
Actual treatment practices of pulmonary nontuberculous mycobacteriosis analysed from national insurance claim data in Japan
K. Morimoto (Tokyo, Japan), K. Izumi (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan)
| |
Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry
M. Loebinger (London, United Kingdom), M. Loebinger (Dundee, United Kingdom), F. Ringshausen (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), P. Goeminne (AZ Nikolaas, Belgium), M. Murris (Toulouse, France), M. Vendrell (Girona, Spain), R. Menendez (Valencia, Spain), R. Wilson (London, United Kingdom), W. Boersma (Alkmaar, Netherlands), A. Hill (Edinburgh, United Kingdom), A. Torres (Barcelona, Spain), K. Dimakou (Athens, Greece), T. Welte (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), F. Blasi (Milan, Italy), S. Elborn (London, United Kingdom), E. Polverino (Barcelona, Spain), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)
| |
Effects of a home programme of airway clearance techniques on adventitious respiratory sounds in patients with bronchiectasis: a randomised controlled trial
B. Herrero Cortina (Zaragoza, Spain), O. Membrado-Lope (Zaragoza, Spain), M. San Miguel-Pagola (Zaragoza, Spain), M. Francín-Gallego (Zaragoza, Spain), J. Saez-Perez (Zaragoza, Spain), E. Polverino (Barcelona, Spain)
| |
Rhinosinusitis is associated with increased symptoms and more frequent exacerbations among patients with bronchiectasis- data from the EMBARC registry
M. Shteinberg (Haifa, Israel), P. Goeminne (Leuven, Belgium), M. Loebinger (London, United Kingdom), C. Haworth (Cambridge, United Kingdom), F. Ringshausen (Hannover, Germany), K. Dimakou (Athens, Greece), M. Murris (Toulouse, France), M. Vendrell (Girona, Spain), R. Menendez (Valencia, Spain), R. Wilson (London, United Kingdom), A. Hill (Edinburgh, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milan, Italy), A. De Soyza (Newcastle upon Tyne, United Kingdom), S. Elborn (Belfast, United Kingdom), E. Polverino (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, United Kingdom)
| |
AMPK is inhibited in severe bronchiectasis and may relate to reduced ciliary beat frequency
Y. Giam (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), M. Contarini (Milan, Italy), D. Cassidy (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Comparison of bronchiectasis cohorts from tertiary centres in Sydney, Milan and Dundee reveal differences in severity and patterns of care
S. Visser (Sydney, Australia), E. Stroil-Salama (Brisbane, Australia), M. Peters (Sydney, Australia), D. Lui (Sydney, Australia), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom), L. Morgan (Sydney, Australia)
| |
Quality of life in patients with non-cystic fibrosis bronchiectasis based on radiologic findings
C. Satici (Istanbul, Turkey), B. Arpinar Yigitbas (Istanbul, Turkey), E. Niksarlioglu (Istanbul, Turkey), M. Demirkol (Istanbul, Turkey), G. Köybasi (Istanbul, Turkey), A. Kosar (Istanbul, Turkey)
| |
Chest Physiotherapy in patients with Bronchiectasis – what is the current practice in Europe?
M. Pinto Mendes (Vila Nova de Gaia, Portugal), S. Finch (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), E. Polverino (Barcelona, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle Upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Sint-Niklaas , Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menéndez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)
| |
Impact of six-minute walk test on health-related quality of life in pulmonary Mycobacterium avium complex disease
K. Yagi (Tokyo, Japan), T. Asakura (Tokyo, Japan), H. Namkoong (Tokyo, Japan), S. Suzuki (Tokyo, Japan), T. Asami (Tokyo, Japan), S. Okamori (Tokyo, Japan), T. Kusumoto (Tokyo, Japan), Y. Funatsu (Tokyo, Japan), H. Kamata (Tokyo, Japan), T. Nishimura (Tokyo, Japan), M. Ishii (Tokyo, Japan), T. Betsuyaku (Tokyo, Japan), N. Hasegawa (Tokyo, Japan)
| |
Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry
M. Pinto Mendes (Vila Nova de Gaia, Portugal), S. Finch (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), E. Polverino (Barceloma, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne (Sint-Niklaas, Belgium), W. Boersma (Alkmaar, Netherlands), C. Haworth (Cambridge, United Kingdom), M. Murris (Toulouse, France), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menéndez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)
| |
Open-label extension (OLE) of ORBIT-3 and ORBIT-4 trials of ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB)
A. O'Donnell (Washington, DC, United States of America), I. Gonda (Hayward, CA, United States of America), D. Cipolla (Hayward, CA, United States of America), J. Froehlich (Hayward, CA, United States of America), A. Davis (Research Triangle Park, NC, United States of America), C. Haworth (Cambridge, United Kingdom)
| |
Neutrophil elastase increases ciliary beat frequency ex-vivo: implications for the bronchiectasis airway
M. Contarini (Milan, Italy), Y. Giam (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Primary ciliary dyskinesia in adults with bronchiectasis: Data from the Embarc registry
A. Shoemark (Dundee, United Kingdom), E. Polverino (Barcelona, Spain), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (- Newcastle upon Tyne, United Kingdom), M. Vendrell (Girona, Spain), P. Goeminne ( Sint Niklaas, Belgium), W. Boersma ( Alkmaar, Netherlands), C. Haworth ( Cambridge, United Kingdom), M. Murris ( Toulouse, France), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menéndez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), R. Wilson (London, United Kingdom), S. Elborn (London, United Kingdom), S. Alberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)
| |